You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 14, 2025

Drugs Containing Excipient (Inactive Ingredient) HYDROXYPROPYL CELLULOSE


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing HYDROXYPROPYL CELLULOSE excipient, and estimated key patent expiration / generic entry dates

CompanyTradenameIngredientNDCExcipientPotential Generic Entry
Eli Lilly and Company CIALIS tadalafil 0002-4465 HYDROXYPROPYL CELLULOSE
ER Squibb & Sons LLC SPRYCEL dasatinib 0003-0527 HYDROXYPROPYL CELLULOSE
Eli Lilly and Company ZYPREXA olanzapine 0002-4112 HYDROXYPROPYL CELLULOSE
>Company>Tradename>Ingredient>NDC>Excipient>Potential Generic Entry
Showing 1 to 3 of 3 entries

Market Dynamics and Financial Trajectory for Hydroxypropyl Cellulose as a Pharmaceutical Excipient

Introduction to Hydroxypropyl Cellulose

Hydroxypropyl cellulose (HPC) is a derivative of cellulose, a natural polymer, and is widely used as an excipient in the pharmaceutical industry. Its versatility and unique properties make it an essential component in various formulations.

Market Size and Growth

The global hydroxypropyl cellulose market, particularly in the pharmaceutical sector, is experiencing significant growth. By 2032, the medical grade hydroxypropyl cellulose market is expected to reach USD 93.25 million, growing at a Compound Annual Growth Rate (CAGR) of 6.2%[2].

Key Drivers of the Market

Pharmaceutical Formulations

One of the primary drivers of the hydroxypropyl cellulose market is its extensive use in pharmaceutical formulations. HPC is used as a disintegrator and film former, which are critical roles in the production of tablets, capsules, and ophthalmic preparations. The increasing demand for ophthalmic drugs, driven by the rising prevalence of eye diseases, further boosts the market[4].

Ophthalmic Formulations

Ophthalmic formulations are another significant segment driving the demand for hydroxypropyl cellulose. HPC's properties make it an ideal excipient for eye drops and other ophthalmic products, contributing to the market's growth[2].

Economic and Industrial Development

Economic development in regions such as Asia-Pacific, particularly in countries like China, India, and Southeast Asia, is driving the market. Increasing per capita disposable income and industrial investments in the pharmaceutical and cosmetics sectors are key factors[1].

Market Segmentation

Type

The medical grade hydroxypropyl cellulose market is segmented into two main types: Low-Substituted Hydroxypropyl Cellulose (L-HPC) and High-Substituted Hydroxypropyl Cellulose (H-HPC). Each type has specific applications and properties that cater to different pharmaceutical needs[2].

Application

By application, the market is segmented into disintegrators and film formers. These applications are crucial in the production of various pharmaceutical products, ensuring the effective release of active ingredients and the stability of the formulations[2].

Regional Analysis

Asia-Pacific

Asia-Pacific is projected to be the leading regional market for hydroxypropyl cellulose, driven by the shifting manufacturing base of fast-moving consumer goods (FMCGs) and other consumer goods to emerging economies. Countries like China, India, Indonesia, Malaysia, and Vietnam are experiencing significant economic growth, which is expected to drive the demand for HPC in the region[1].

Middle East & Africa

The Middle East and Africa are also expected to witness significant growth due to growing infrastructure and remodeling activities. These regions are seeing an increase in pharmaceutical and construction activities, which will contribute to the demand for hydroxypropyl cellulose[1].

Challenges and Restraints

Government Regulations

One of the main challenges facing the hydroxypropyl cellulose market is government limitations on its use as a food additive. These regulations can hinder the market's growth, as they restrict the potential applications of HPC[4].

Opportunities

Textile Industry

The textile industry presents an opportunity for the hydroxypropyl cellulose market. HPC's properties make it a suitable material for various textile applications, which could expand its market scope beyond pharmaceuticals[4].

FMCG and Consumer Goods

The increasing demand from FMCGs and other consumer goods, particularly in emerging economies, offers a significant opportunity for the hydroxypropyl cellulose market. HPC's wide application scope in these industries is expected to drive growth[1].

Financial Trajectory

The global hydroxypropyl cellulose market, including its pharmaceutical segment, is expected to grow substantially. Here are some key financial projections:

  • Market Size: The global hydroxypropyl cellulose market size reached USD 206.48 million in 2023 and is expected to grow at a CAGR of 7.84% from 2024 to 2032[5].
  • Medical Grade Segment: The medical grade hydroxypropyl cellulose market is expected to reach USD 93.25 million by 2032, growing at a CAGR of 6.2%[2].

Industry Trends

Increasing Demand for Pharmaceutical Products

The pharmaceutical industry is experiencing a surge in demand for various products, including ophthalmic drugs and sustained-release preparations. This trend is driving the demand for hydroxypropyl cellulose as a critical excipient[3].

Technological Advancements

Advancements in pharmaceutical technology are leading to the development of new formulations that require high-quality excipients like hydroxypropyl cellulose. This is further boosting the market's growth[3].

Regulatory Compliance

Companies are focusing on ensuring regulatory compliance, which includes the use of high-quality excipients like hydroxypropyl cellulose. This emphasis on compliance is driving the demand for medical-grade HPC[3].

Key Takeaways

  • The hydroxypropyl cellulose market is driven by its extensive use in pharmaceutical formulations, particularly in ophthalmic and disintegrator applications.
  • Asia-Pacific is expected to be the leading regional market due to economic development and industrial investments.
  • Government regulations on food additives are a significant restraint, but opportunities in the textile and FMCG sectors offer potential for growth.
  • The market is expected to grow at a CAGR of 6.2% for the medical grade segment and 7.84% for the overall market.

FAQs

What is the expected market size of the medical grade hydroxypropyl cellulose market by 2032?

The medical grade hydroxypropyl cellulose market is expected to reach USD 93.25 million by 2032[2].

What is the CAGR of the medical grade hydroxypropyl cellulose market from 2024 to 2032?

The medical grade hydroxypropyl cellulose market is expected to exhibit a CAGR of 6.2% from 2024 to 2032[2].

Which regions are expected to drive the growth of the hydroxypropyl cellulose market?

Asia-Pacific, particularly countries like China, India, and Southeast Asia, are expected to drive the growth of the hydroxypropyl cellulose market[1].

What are the primary applications of hydroxypropyl cellulose in the pharmaceutical industry?

The primary applications of hydroxypropyl cellulose in the pharmaceutical industry are as disintegrators and film formers[2].

Are there any challenges facing the hydroxypropyl cellulose market?

Yes, government limitations on the use of hydroxypropyl cellulose as food additives are a significant challenge facing the market[4].

Sources

  1. Grand View Research - Hydroxypropyl Cellulose Market Size | Global Industry Report, 2025
  2. Business Research Insights - Medical Grade Hydroxypropyl Cellulose Market Size, Trend 2032
  3. Market Research Intellect - Global Pharmaceutical Cellulose Derivative Excipient Market Size ...
  4. Mordor Intelligence - Hydroxypropyl Cellulose Market Size & Share Analysis
  5. News Channel Nebraska - Global Hydroxypropyl Cellulose HPC Market [2024-2032] | An Insightful Analysis on Industry Trends and Forecast

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.